Table 3.
Autoimmunity analysis in patients with acquired generalised lipodystrophy.
| Case No. | Anti-GAD | Anti-IA2 | Anti-IAA | Anti-TPO | Anti-Tg | ANA | ATA | APCA | ADR | RF |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | + | - | + | - | - | NA | - | NA | + | NA |
| 2 | - | - | - | - | - | - | - | + | NA | NA |
| 3 | - | - | - | - | - | NA | + | - | NA | NA |
| 4 | - | - | - | + | - | + | - | - | - | NA |
| 5 | + | + | - | - | - | + | - | NA | NA | - |
| 6 | + | - | - | + | - | - | + | - | - | NA |
| 7 | - | - | - | - | - | NA | NA | NA | - | + |
+: positive result; -: negative result; NA: not available; Anti-GAD: anti-glutamic acid decarboxylase; anti-IA2: anti-islet cell; anti-IAA: anti-insulin; anti-TPO: anti-thyroid peroxidase; anti-Tg: anti-thyroglobulin; ANA: anti-nuclear antibodies; ATA: anti-transglutaminase antibodies; APCA: anti-parietal cell antibodies; ADR: anti-adrenal antibody; RF: rheumatoid factor.